Montelukast does not appear to increase the risk for neuropsychiatric adverse events in children and adolescents, according to a study published in JAMA Pediatrics. Montelukast is a leukotriene ...

Australia's Therapeutic Goods Administration (TGA) recently issued a safety alert requiring extra warnings to be included ...

Montelukast, a well-known antagonist of the cysteinyl leukotriene receptor 1, has been widely used for managing asthma symptoms. However, recent studies have suggested its potential for ...

But NICE is now advising for the first time that a leukotriene receptor antagonist (LTRA) tablet such as montelukast should be offered before more expensive combination treatments such as Seretide.

In fact, many studies show that nasal steroids are better at treating allergy symptoms than oral antihistamines, nasal antihistamine sprays or Singulair (montelukast ... A comparison study of ...

Research in the authors' laboratory is funded by the MRC, BMA and Asthma UK. M Portelli is funded by a STEPS (Malta) studentship. The authors have no other relevant affiliations or financial ...